Injectable Coacervate Hydrogel for Delivery of Anticancer Drug-Loaded Nanoparticles in vivo
Author:
Affiliation:
1. Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, Singapore 138669, Singapore
2. IBM Almaden Research Center, 650 Harry Road, San Jose, California 95120, United States
Funder
International Business Machines Corporation
Institute of Bioengineering and Nanotechnology, Agency for Science, Technology and Research
Publisher
American Chemical Society (ACS)
Subject
General Materials Science
Link
https://pubs.acs.org/doi/pdf/10.1021/acsami.7b14319
Reference42 articles.
1. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
2. Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy
3. A Proteasome Inhibitor, Bortezomib, Inhibits Breast Cancer Growth and Reduces Osteolysis by Downregulating Metastatic Genes
4. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements in drugs restructured with nanomedicines for multiple myeloma treatment;Science China Materials;2024-09-10
2. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12
3. Multifunctional Hydrogels for Biomedical Applications;Nano Biomedicine and Engineering;2024-08
4. Underwater Fabrication of Carbon Nanotube/Coacervate Composites;Langmuir;2024-06-10
5. Preparation and properties of acrylate/polyvinyl alcohol self-healing hydrogels based on hydrogen bonds and coordination bonds;Journal of Polymer Engineering;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3